Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > 200 DMA

<< Previous

Bullboard Posts

Next >>

Comment by 007daveon Sep 12, 2020 11:42pm

115 Views

Post# 31549320

RE:RE:RE:200 DMA

Of course the stock price will increase if they get vet sales, but i believe that is the difference between a 2 dollar stock and a 10 dollar stock with FDA EUA. And what will be the cash burn in the meantime. One more point Shake if they do release negative news on any delays in manufacturing or FDA how much of the latest bought deal would they have sold. No chance they would have raised 13 mil, and the price would have been much lower than .85 and much more dilution.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario